Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System
Recently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for e...
Saved in:
Published in | Frontiers in oncology Vol. 12; p. 861867 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
30.06.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 2234-943X 2234-943X |
DOI | 10.3389/fonc.2022.861867 |
Cover
Abstract | Recently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for esophageal cancer. However, there was no previous study to explore the role of FDG PET/CT in the staging system based on the 8th edition. The prognostic value of FDG PET/CT was investigated in patients with esophageal squamous cell carcinoma (SqCC) considering the new 8th AJCC/UICC staging system.
Subjects were 721 patients with esophageal SqCC undergoing pretherapeutic FDG PET/CT. Clinico-pathological variables and the maximum standardized uptake value (SUVmax) of the primary tumor were included in survival analysis. Subgroup analysis was performed to compare hazard ratios according to pathological stage and SUVmax. A new staging classification including FDG uptake was proposed.
In multivariate survival analysis, pathological stage and SUVmax of the primary tumor were selected as independent prognostic factors for overall survival in both the 7th and 8th editions. The proposed new staging system showed better discrimination for overall survival between stage I and II than did the conventional staging system (hazard ratios: 2.250 vs. 1.341).
The FDG uptake of the primary tumor was found to be an independent prognostic factor along with pathological stage based on both 7th and 8th AJCC/UICC staging systems in patients with esophageal SqCC. The suggested new staging system including SUVmax was better for predicting prognoses than the conventional staging system. |
---|---|
AbstractList | IntroductionRecently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for esophageal cancer. However, there was no previous study to explore the role of FDG PET/CT in the staging system based on the 8th edition. The prognostic value of FDG PET/CT was investigated in patients with esophageal squamous cell carcinoma (SqCC) considering the new 8th AJCC/UICC staging system.MethodsSubjects were 721 patients with esophageal SqCC undergoing pretherapeutic FDG PET/CT. Clinico-pathological variables and the maximum standardized uptake value (SUVmax) of the primary tumor were included in survival analysis. Subgroup analysis was performed to compare hazard ratios according to pathological stage and SUVmax. A new staging classification including FDG uptake was proposed.ResultsIn multivariate survival analysis, pathological stage and SUVmax of the primary tumor were selected as independent prognostic factors for overall survival in both the 7th and 8th editions. The proposed new staging system showed better discrimination for overall survival between stage I and II than did the conventional staging system (hazard ratios: 2.250 vs. 1.341).ConclusionsThe FDG uptake of the primary tumor was found to be an independent prognostic factor along with pathological stage based on both 7th and 8th AJCC/UICC staging systems in patients with esophageal SqCC. The suggested new staging system including SUVmax was better for predicting prognoses than the conventional staging system. Recently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for esophageal cancer. However, there was no previous study to explore the role of FDG PET/CT in the staging system based on the 8th edition. The prognostic value of FDG PET/CT was investigated in patients with esophageal squamous cell carcinoma (SqCC) considering the new 8th AJCC/UICC staging system. Subjects were 721 patients with esophageal SqCC undergoing pretherapeutic FDG PET/CT. Clinico-pathological variables and the maximum standardized uptake value (SUVmax) of the primary tumor were included in survival analysis. Subgroup analysis was performed to compare hazard ratios according to pathological stage and SUVmax. A new staging classification including FDG uptake was proposed. In multivariate survival analysis, pathological stage and SUVmax of the primary tumor were selected as independent prognostic factors for overall survival in both the 7th and 8th editions. The proposed new staging system showed better discrimination for overall survival between stage I and II than did the conventional staging system (hazard ratios: 2.250 vs. 1.341). The FDG uptake of the primary tumor was found to be an independent prognostic factor along with pathological stage based on both 7th and 8th AJCC/UICC staging systems in patients with esophageal SqCC. The suggested new staging system including SUVmax was better for predicting prognoses than the conventional staging system. Recently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for esophageal cancer. However, there was no previous study to explore the role of FDG PET/CT in the staging system based on the 8th edition. The prognostic value of FDG PET/CT was investigated in patients with esophageal squamous cell carcinoma (SqCC) considering the new 8th AJCC/UICC staging system.IntroductionRecently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for esophageal cancer. However, there was no previous study to explore the role of FDG PET/CT in the staging system based on the 8th edition. The prognostic value of FDG PET/CT was investigated in patients with esophageal squamous cell carcinoma (SqCC) considering the new 8th AJCC/UICC staging system.Subjects were 721 patients with esophageal SqCC undergoing pretherapeutic FDG PET/CT. Clinico-pathological variables and the maximum standardized uptake value (SUVmax) of the primary tumor were included in survival analysis. Subgroup analysis was performed to compare hazard ratios according to pathological stage and SUVmax. A new staging classification including FDG uptake was proposed.MethodsSubjects were 721 patients with esophageal SqCC undergoing pretherapeutic FDG PET/CT. Clinico-pathological variables and the maximum standardized uptake value (SUVmax) of the primary tumor were included in survival analysis. Subgroup analysis was performed to compare hazard ratios according to pathological stage and SUVmax. A new staging classification including FDG uptake was proposed.In multivariate survival analysis, pathological stage and SUVmax of the primary tumor were selected as independent prognostic factors for overall survival in both the 7th and 8th editions. The proposed new staging system showed better discrimination for overall survival between stage I and II than did the conventional staging system (hazard ratios: 2.250 vs. 1.341).ResultsIn multivariate survival analysis, pathological stage and SUVmax of the primary tumor were selected as independent prognostic factors for overall survival in both the 7th and 8th editions. The proposed new staging system showed better discrimination for overall survival between stage I and II than did the conventional staging system (hazard ratios: 2.250 vs. 1.341).The FDG uptake of the primary tumor was found to be an independent prognostic factor along with pathological stage based on both 7th and 8th AJCC/UICC staging systems in patients with esophageal SqCC. The suggested new staging system including SUVmax was better for predicting prognoses than the conventional staging system.ConclusionsThe FDG uptake of the primary tumor was found to be an independent prognostic factor along with pathological stage based on both 7th and 8th AJCC/UICC staging systems in patients with esophageal SqCC. The suggested new staging system including SUVmax was better for predicting prognoses than the conventional staging system. |
Author | Min, Yang Won Shim, Young Mog Lee, Kyung Soo Kim, Hong Kwan Zo, Jae Ill Lee, Hyunjong Choi, Joon Young |
AuthorAffiliation | 1 Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea 4 Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea 2 Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine , Seoul , South Korea 3 Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea |
AuthorAffiliation_xml | – name: 1 Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea – name: 3 Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea – name: 2 Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine , Seoul , South Korea – name: 4 Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea |
Author_xml | – sequence: 1 givenname: Hyunjong surname: Lee fullname: Lee, Hyunjong – sequence: 2 givenname: Kyung Soo surname: Lee fullname: Lee, Kyung Soo – sequence: 3 givenname: Yang Won surname: Min fullname: Min, Yang Won – sequence: 4 givenname: Hong Kwan surname: Kim fullname: Kim, Hong Kwan – sequence: 5 givenname: Jae Ill surname: Zo fullname: Zo, Jae Ill – sequence: 6 givenname: Young Mog surname: Shim fullname: Shim, Young Mog – sequence: 7 givenname: Joon Young surname: Choi fullname: Choi, Joon Young |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35847839$$D View this record in MEDLINE/PubMed |
BookMark | eNp1Uk1r3DAQNSWlSdPceyo69rK7-rC00qUQnE26JdDAbqA3MZYlr4ItJZK3kP762t00JIXqMoPmvTea0XtfHIUYbFF8JHjOmFQLF4OZU0zpXAoixfJNcUIpK2eqZD-OXuTHxVnOd3g8gmOC2bvimHFZLiVTJ8WvmxTbEPPgDdr4NnjnDQRjUXTo8uIK3ay2i2qLfECrHO930Fro0OZhD33cZ1TZrkMVJOND7GFCDTuLVgkm-pTKYYfOv1XV4nZdVWgzQOtDizaPebD9h-Ktgy7bs6d4WtxerrbV19n196t1dX49M6Wgw6wGzBVIB0oJp3hTl0JY1UgKvHGMjAVBGmIdw8rUoiacE2mlNbSpLZOsZKfF-qDbRLjT98n3kB51BK__XMTUakjj_J3VQnIODQbBuSidhZpbJ2sqjOFqyZd21Ppy0Lrf171tjA1Dgu6V6OtK8Dvdxp9aUYmVJKPA5yeBFB_2Ng-699mMa4Rgx41qKhQpuSTLCfrpZa_nJn8_bwTgA8CkmHOy7hlCsJ4soieL6Mki-mCRkSL-oRg_wODj9Frf_Z_4G104wLg |
CitedBy_id | crossref_primary_10_1016_j_semradonc_2023_03_006 crossref_primary_10_1007_s00330_024_11207_3 crossref_primary_10_1186_s40644_024_00811_7 |
Cites_doi | 10.3346/jkms.2016.31.1.39 10.4251/wjgo.v6.i5.139 10.1002/9780471420194.tnmc26.pub3 10.1136/gutjnl-2014-308124 10.1007/s00595-014-0965-6 10.1097/MEG.0b013e328323d6fa 10.1002/cncr.24399 10.3322/caac.21660 10.1186/s40644-019-0225-5 10.1148/radiol.2363041310 10.4251/wjgo.v6.i5.112 10.1177/107327481302000202 10.1007/s11605-009-1038-9 10.1016/j.suc.2012.07.013 10.2967/jnumed.114.148056 10.1245/s10434-011-1732-1 10.1097/01.mnm.0000134329.30912.49 10.1097/MNM.0b013e3282f81423 10.1097/RLU.0000000000002291 10.1007/s13139-020-00642-x 10.1259/bjr/73516936 10.1016/j.athoracsur.2006.03.045 10.1245/s10434-009-0719-7 10.1093/jjco/hyaa082 10.1016/j.ejso.2017.06.005 10.1097/MNM.0000000000000837 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi. Copyright © 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi |
Copyright_xml | – notice: Copyright © 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi. – notice: Copyright © 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fonc.2022.861867 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2234-943X |
ExternalDocumentID | oai_doaj_org_article_6855ad0a65564feab5ef8b26cc59757e PMC9280981 35847839 10_3389_fonc_2022_861867 |
Genre | Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EJD EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM ACXDI IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c462t-ba059a8fa996f95db466e9d82a5df318fa61d1ef309cb6b15518e8ec2dbe38343 |
IEDL.DBID | M48 |
ISSN | 2234-943X |
IngestDate | Wed Aug 27 01:30:15 EDT 2025 Thu Aug 21 18:28:37 EDT 2025 Fri Sep 05 09:59:47 EDT 2025 Mon Jul 21 06:05:36 EDT 2025 Wed Oct 01 01:24:59 EDT 2025 Thu Apr 24 23:04:20 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | 8th AJCC staging system esophageal cancer FDG PET/CT prognosis squamous cell carcinoma |
Language | English |
License | Copyright © 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-ba059a8fa996f95db466e9d82a5df318fa61d1ef309cb6b15518e8ec2dbe38343 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Alessio G. Morganti, University of Bologna, Italy This article was submitted to Gastrointestinal Cancers: Gastric & Esophageal Cancers, a section of the journal Frontiers in Oncology Reviewed by: Long-Qi Chen, Sichuan University, China; Guobing Liu, Fudan University, China |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fonc.2022.861867 |
PMID | 35847839 |
PQID | 2691458171 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_6855ad0a65564feab5ef8b26cc59757e pubmedcentral_primary_oai_pubmedcentral_nih_gov_9280981 proquest_miscellaneous_2691458171 pubmed_primary_35847839 crossref_primary_10_3389_fonc_2022_861867 crossref_citationtrail_10_3389_fonc_2022_861867 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-06-30 |
PublicationDateYYYYMMDD | 2022-06-30 |
PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-30 day: 30 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in oncology |
PublicationTitleAlternate | Front Oncol |
PublicationYear | 2022 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Shim (B13) 2005; 236 B27 Kato (B25) 2009; 115 Yildirim (B17) 2018; 39 Omloo (B20) 2011; 18 Napier (B3) 2014; 6 Karashima (B6) 2015; 45 Brierley (B10) 2017 Almhanna (B4) 2013; 20 Sung (B1) 2021; 71 Cerfolio (B22) 2006; 82 Zhang (B26) 2017; 43 Sepesi (B24) 2009; 13 Sunderland (B28) 2015; 56 Park (B15) 2020; 54 Al-Taan (B21) 2014; 6 Arnold (B2) 2015; 64 Lee (B8) 2019; 19 Daiko (B11) 2020; 50 Lucignani (B14) 2004; 25 Cheze-Le Rest (B23) 2008; 29 Heeren (B7) 2004; 45 Pan (B9) 2009; 21 Kim (B12) 2012; 85 Hong (B18) 2016; 31 Han (B16) 2018; 43 Hyun (B19) 2010; 17 Cooper (B5) 2012; 92 39529838 - Front Oncol. 2024 Oct 28;14:1505996. doi: 10.3389/fonc.2024.1505996 |
References_xml | – volume: 45 year: 2004 ident: B7 article-title: Detection of Distant Metastases in Esophageal Cancer With 18F-FDG PET publication-title: J Nucl Med – volume: 31 start-page: 39 year: 2016 ident: B18 article-title: Total Lesion Glycolysis Using 18F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer publication-title: J Korean Med Sci doi: 10.3346/jkms.2016.31.1.39 – volume: 6 year: 2014 ident: B21 article-title: Prognostic Value of Baseline FDG Uptake on PET-CT in Esophageal Carcinoma publication-title: World J Gastrointest Oncol doi: 10.4251/wjgo.v6.i5.139 – start-page: 57 year: 2017 ident: B10 article-title: TNM Classification of Malignant Tumours: John Wiley & Sons doi: 10.1002/9780471420194.tnmc26.pub3 – volume: 64 year: 2015 ident: B2 article-title: Global Incidence of Oesophageal Cancer by Histological Subtype in 2012 publication-title: Gut doi: 10.1136/gutjnl-2014-308124 – volume: 45 year: 2015 ident: B6 article-title: Advantages of FDG-PET/CT Over CT Alone in the Preoperative Assessment of Lymph Node Metastasis in Patients With Esophageal Cancer publication-title: Surg Today doi: 10.1007/s00595-014-0965-6 – volume: 21 year: 2009 ident: B9 article-title: Prognostic Significance of SUV on PET/CT in Patients With Esophageal Cancer: A Systematic Review and Meta-Analysis publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0b013e328323d6fa – ident: B27 – volume: 115 year: 2009 ident: B25 article-title: The Clinical Application of 18F-Fluorodeoxyglucose Positron Emission Tomography to Predict Survival in Patients With Operable Esophageal Cancer publication-title: Cancer doi: 10.1002/cncr.24399 – volume: 71 year: 2021 ident: B1 article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 19 start-page: 40 year: 2019 ident: B8 article-title: Improved Detection of Metastatic Lymph Nodes in Oesophageal Squamous Cell Carcinoma by Combined Interpretation of Fluorine-18-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography publication-title: Cancer Imaging doi: 10.1186/s40644-019-0225-5 – volume: 236 year: 2005 ident: B13 article-title: Non–small Cell Lung Cancer: Prospective Comparison of Integrated FDG PET/CT and CT Alone for Preoperative Staging publication-title: Radiology doi: 10.1148/radiol.2363041310 – volume: 6 year: 2014 ident: B3 article-title: Esophageal Cancer: A Review of Epidemiology, Pathogenesis, Staging Workup and Treatment Modalities publication-title: World J Gastrointest Oncol doi: 10.4251/wjgo.v6.i5.112 – volume: 20 start-page: 89 year: 2013 ident: B4 article-title: Neoadjuvant or Adjuvant Therapy for Resectable Esophageal Cancer: Is There a Standard of Care publication-title: Cancer Control doi: 10.1177/107327481302000202 – volume: 13 year: 2009 ident: B24 article-title: Does the Value of PET-CT Extend Beyond Pretreatment Staging? An Analysis of Survival in Surgical Patients With Esophageal Cancer publication-title: J Gastrointest Surg doi: 10.1007/s11605-009-1038-9 – volume: 92 year: 2012 ident: B5 article-title: Definitive Chemoradiotherapy for Esophageal Carcinoma publication-title: Surg Clin North Am doi: 10.1016/j.suc.2012.07.013 – volume: 56 year: 2015 ident: B28 article-title: Quantitative PET/CT Scanner Performance Characterization Based Upon the Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network Oncology Clinical Simulator Phantom publication-title: J Nucl Med doi: 10.2967/jnumed.114.148056 – volume: 18 year: 2011 ident: B20 article-title: FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review publication-title: Ann Surg Oncol doi: 10.1245/s10434-011-1732-1 – volume: 25 year: 2004 ident: B14 article-title: The Use of Standardized Uptake Values for Assessing FDG Uptake With PET in Oncology: A Clinical Perspective publication-title: Nucl Med Commun doi: 10.1097/01.mnm.0000134329.30912.49 – volume: 29 year: 2008 ident: B23 article-title: Prognostic Value of Initial Fluorodeoxyglucose-PET in Esophageal Cancer: A Prospective Study publication-title: Nucl Med Commun doi: 10.1097/MNM.0b013e3282f81423 – volume: 43 year: 2018 ident: B16 article-title: Prognostic Value of Volumetric Parameters of Pretreatment 18F-FDG PET/CT in Esophageal Cancer: A Systematic Review and Meta-Analysis publication-title: Clin Nucl Med doi: 10.1097/RLU.0000000000002291 – volume: 54 year: 2020 ident: B15 article-title: Radiogenomics Based on PET Imaging publication-title: Nucl Med Mol Imaging doi: 10.1007/s13139-020-00642-x – volume: 85 year: 2012 ident: B12 article-title: Hounsfield Units Upon PET/CT are Useful in Evaluating Metastatic Regional Lymph Nodes in Patients With Oesophageal Squamous Cell Carcinoma publication-title: Br J Radiol doi: 10.1259/bjr/73516936 – volume: 82 year: 2006 ident: B22 article-title: Maximum Standardized Uptake Values on Positron Emission Tomography of Esophageal Cancer Predicts Stage, Tumor Biology, and Survival publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2006.03.045 – volume: 17 year: 2010 ident: B19 article-title: Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Esophageal Carcinoma publication-title: Ann Surg Oncol doi: 10.1245/s10434-009-0719-7 – volume: 50 year: 2020 ident: B11 article-title: Updates in the 8th Edition of the TNM Staging System for Esophagus and Esophagogastric Junction Cancer publication-title: Jpn J Clin Oncol doi: 10.1093/jjco/hyaa082 – volume: 43 year: 2017 ident: B26 article-title: Comparison of the 7th and Proposed 8th Editions of the AJCC/UICC TNM Staging System for Esophageal Squamous Cell Carcinoma Underwent Radical Surgery publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2017.06.005 – volume: 39 year: 2018 ident: B17 article-title: Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Esophageal Carcinoma Patients Treated With Definitive Chemoradiotherapy publication-title: Nucl Med Commun doi: 10.1097/MNM.0000000000000837 – reference: 39529838 - Front Oncol. 2024 Oct 28;14:1505996. doi: 10.3389/fonc.2024.1505996 |
SSID | ssj0000650103 |
Score | 2.3228774 |
Snippet | Recently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18... IntroductionRecently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 861867 |
SubjectTerms | 8th AJCC staging system esophageal cancer FDG PET/CT Oncology prognosis squamous cell carcinoma |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQD4gLonyGAjISFw4hiWM79rGEXUolUKXuSr1ZtmPTlZYEVtsLv56ZOF3tIgQXblFiO9bM2PNGM3pDyBurm1KBn8ltxyFAEZ3MHTLQ1k6r2grMnI1Vvl_k2ZKfX4mrvVZfWBOW6IGT4AqphLBdaaUQksdgnQhROSa9BygsmoC3L7ixvWAq3cECGxikvCREYbqIQ4-MhYy9U0gR3xz4oZGu_08Y8_dSyT3fM39A7k-gkZ6mzR6TO6F_SO5-ntLij8jPi82ABXPwmV6uvvZY_oPapEOk8w8f6cVsUbQLuurpDLsWwBUCq13-uLEY99M2rNe0xZ5C_fDN4igAhXS2sTgdH9X2mp6et22x_NS2FOApNjaiiev8MVnOZ4v2LJ-aKuSeS7bNnQVAZVW0EOhELTrHpQy6U8yKLsIBj1ZWXRViXWrvpBsZ24IKnnUuQDTL6yfkqB_68IxQAGuqY942VivuBXcKwIBnsfRVA4u4jBS3IjZ-YhzHxhdrA5EHKsWgUgwqxSSlZOTtbsb3xLbxl7HvUWu7cciTPb4A6zGT9Zh_WU9GXt_q3MC5wmSJ7QPI3jCpKy5U1VQZeZpsYPerGnPLgCwz0hxYx8FeDr_0q-uRu1szVWpVPf8fmz8h91AeqXrxBTnabm7CS4BIW_dqPA2_ACkZDfc priority: 102 providerName: Directory of Open Access Journals |
Title | Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35847839 https://www.proquest.com/docview/2691458171 https://pubmed.ncbi.nlm.nih.gov/PMC9280981 https://doaj.org/article/6855ad0a65564feab5ef8b26cc59757e |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2234-943X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000650103 issn: 2234-943X databaseCode: KQ8 dateStart: 20110101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2234-943X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000650103 issn: 2234-943X databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2234-943X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000650103 issn: 2234-943X databaseCode: DIK dateStart: 20110101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2234-943X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000650103 issn: 2234-943X databaseCode: GX1 dateStart: 20110101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2234-943X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000650103 issn: 2234-943X databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2234-943X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000650103 issn: 2234-943X databaseCode: RPM dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2234-943X dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0000650103 issn: 2234-943X databaseCode: M48 dateStart: 20110601 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdgSIgXxPcyYDISLzxkTRzbsR8QGqHdmDQ0aa3Ut8h27K1SSbbQScBfz12SFYoqJF6ifDhO4rN9v_NdfkfIW6PzRIGeiU3FwUARlYwtMtBmVqvMCPScdVG-X-TxjJ_Mxfz379FDA37batphPqlZuzz4fv3jAwz492hxgr4dhaZGMkLGDhSyv-d3yT3QSwz7-OkA9vt5WWBSA8w2xzIea57Ne7_l1ko29FRH578Ng_4dSvmHbpo8Ig8HUEkP-17wmNzx9RNy_3Rwmz8lP8_aBgPq4DI9X1zUGB6E0qZNoJNPR_RsPB0VU7qo6RizGsAUA7WdX98YXBeghV8uaYE5h-rmq8FSABrpuDV4O-6q1SU9PCmK0exzUVCAr5j4iPZc6M_IbDKeFsfxkHQhdlyyVWwNAC6jggFDKGhRWS6l15ViRlQBJoBgZFqlPmSJdlbajtHNK-9YZT1Yuzx7Tnbqpva7hAKYUxVzJjdacSe4VQAWHAuJS3OoxEZkdNvEpRsYyTExxrIEywSFUqJQShRK2QslIu_Wd1z1bBz_KPsRpbYuhzza3YmmvSiHYVlKJYSpEiOFkDx4Y4UPyjLpHBhaIvcReXMr8xLGHTpTTO2h7UsmdcqFSvM0Ii_6PrB-VIa-Z0CeEck3esfGu2xeqReXHbe3ZirRKt37jw99SR7gUR_E-IrsrNob_xqQ0srudysMsD2ap_vdYPgFefcQGA |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+Significance+of+FDG+PET%2FCT+in+Esophageal+Squamous+Cell+Carcinoma+in+the+Era+of+the+8th+AJCC%2FUICC+Staging+System&rft.jtitle=Frontiers+in+oncology&rft.au=Lee%2C+Hyunjong&rft.au=Lee%2C+Kyung+Soo&rft.au=Min%2C+Yang+Won&rft.au=Kim%2C+Hong+Kwan&rft.date=2022-06-30&rft.issn=2234-943X&rft.eissn=2234-943X&rft.volume=12&rft_id=info:doi/10.3389%2Ffonc.2022.861867&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fonc_2022_861867 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon |